Molecular Immunology Core
Molecular Immunology Core
批准号:
10622125
负责人:
Leslie S Kean
金额:
$54.76万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-23 至 2028-02-29
关键词:
AddressAllograft ToleranceAnimalsAutomobile DrivingBioinformaticsBiologicalBiological AssayBone MarrowBostonCellsClinicClone CellsCollaborationsComplexComputer AnalysisComputer softwareCytomegalovirusDana-Farber Cancer InstituteData SetDevelopmentDisparityEnsureFlow CytometryGeneral HospitalsGraft RejectionHospitalsHuman Herpesvirus 4ImmuneImmune ToleranceImmune responseImmune systemImmunityImmunogeneticsImmunologic MonitoringImmunologyImmunology procedureInformation ManagementLeadLinkLungLung TransplantationMacacaMacaca fascicularisMacaca mulattaMassachusettsMethodologyMinnesotaMolecularMolecular AnalysisMolecular ImmunologyMonitorOutcomePathway interactionsPediatric HospitalsPerformancePhysiciansProceduresRegimenReproducibilityResearchResearch PersonnelSafetySamplingScientistStainsStandardizationSystemSystems AnalysisT cell infiltrationT-LymphocyteTechniquesTranslatingTransplant RecipientsTransplantationTransplantation ToleranceUniversitiesViralVirusVirus LatencyWomanbioinformatics pipelinecell typeclinically relevantdata managementexperimental studyhigh dimensionalitylung allograftmedical schoolsnovelnovel strategiesnovel therapeutic interventionsingle-cell RNA sequencingspatiotemporalsynergismtooltranscriptomicsviral detectionvirology
中文摘要
核心摘要/摘要
MIC将为所有生物的高级细胞和系统免疫分析提供一个集中的中心
来自项目1-2的样本。此外,MIC将协调和简化所有常见的分析和
确保两个项目都采用统一的标准作业程序和最佳做法的程序。
MIC由五个相互作用的子核组成:(1)MHC免疫遗传学和分型核心;(2)Flow
细胞学和细胞因子核心;(3)病毒学和功能保护性免疫核心;(4)分子免疫学
和翻译核心;以及(5)计算分析核心。每个核心都满足一项基本要求
以最佳方式进行项目1-2中提出的复杂实验,并促进协作
调查人员之间。因此,MIC将显著提高我们小组的效率和严谨性
能够执行本U19中提出的肺移植耐受实验。
英文摘要
CORE SUMMARY / ABSTRACT
The MIC will provide a centralized hub for advanced cellular and systems immunological analysis of all biologic
samples derived from Projects 1-2. In addition, the MIC will coordinate and streamline all common assays and
procedures to ensure that both Projects utilize uniform Standard Operating Procedures (SOPs) and best practices.
The MIC is comprised of five interacting sub-Cores: (1) The MHC Immunogenetics and Typing Core; (2) the Flow
Cytometry and CyTOF Core; (3) The Virology and Functional Protective Immunity Core; (4) The Molecular Immunology
and Transcriptomics Core; and (5) The Computational Analysis Core. Each Core addresses an essential requirement
for the optimal conduct of the complex experiments that are proposed in Projects 1-2 and promotes collaboration
between investigators. As such, the MIC will significantly increase the efficiency and the rigor with which our group is
able to execute the lung transplant tolerance experiments proposed in this U19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: The New Era of Cellular Therapies For Lung Transplant Tolerance
-
批准号:10622128
-
项目类别:
-
资助金额:$106.68万
-
财政年份:2023
-
负责人:Leslie S Kean
-
依托单位:
Defining the T Cell Mediators of Clinical Response in Chronic GVHD
-
批准号:10698167
-
项目类别:
-
资助金额:$46.63万
-
财政年份:2022
-
负责人:Leslie S Kean
-
依托单位:
Defining the T Cell Mediators of Clinical Response in Chronic GVHD
-
批准号:10493799
-
项目类别:
-
资助金额:$47.88万
-
财政年份:2022
-
负责人:Leslie S Kean
-
依托单位:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
-
批准号:10270361
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2021
-
负责人:Leslie S Kean
-
依托单位:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
-
批准号:10457401
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2021
-
负责人:Leslie S Kean
-
依托单位:
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
-
批准号:10673079
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2021
-
负责人:Leslie S Kean
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10474806
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2017
-
负责人:Leslie S Kean
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10683141
-
项目类别:
-
资助金额:$98.93万
-
财政年份:2017
-
负责人:Leslie S Kean
-
依托单位:
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
-
批准号:10474994
-
项目类别:
-
资助金额:$99.52万
-
财政年份:2017
-
负责人:Leslie S Kean
-
依托单位:
Integrated Molecular and Cellular Immunology Core
-
批准号:8705988
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:9301086
-
项目类别:
-
资助金额:$55.58万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:8930057
-
项目类别:
-
资助金额:$26.02万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:8841635
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation
-
批准号:9329366
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2014
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8654260
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8821466
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8849765
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Phase 2 Study of Abatacept with Calcineurin Inhibition and Methotrexate for GVHD
-
批准号:8569114
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2013
-
负责人:Leslie S Kean
-
依托单位:
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
-
批准号:9358731
-
项目类别:
-
资助金额:$67.28万
-
财政年份:2010
-
负责人:Leslie S Kean
-
依托单位:
Novel Biologic Therapies for GVHD
-
批准号:10664835
-
项目类别:
-
资助金额:$116.93万
-
财政年份:2010
-
负责人:Leslie S Kean
-
依托单位:
海外基金